Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Fort Worth, Texas 76134


Purpose:

The purpose of this study is to demonstrate that the Intraocular Pressure (IOP) lowering efficacy of Travoprost Ophthalmic Solution 0.004% is superior to that of Pilocarpine 1% in patients with chronic angle-closure glaucoma (CACG).


Criteria:

Inclusion Criteria: - Age ≥ 18 years - Chronic Angle Closure Glaucoma (CACG) - 21-35 millimeters mercury mean intraocular pressure on Eligibility visit day at 9 AM - Peripheral iridotomy performed ≥ 1 Month prior to the Screening visit - Anterior chamber angle in which the trabecular meshwork is not visible for ≥180 degrees in gonioscopy without indentation - Peripheral anterior synechiae (PAS) Exclusion Criteria: - Traumatic damage of the anterior chamber angle - History of ocular inflammation or surgery (except for iridotomy) ≤ 3 months - Patients who cannot be safely discontinued from use of all ocular hypotensive medication(s) for 12 days to 14 weeks - Visual Acuity ≥ 1.0 - Contact lenses wearer


NCT ID:

NCT00762645


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Fort Worth, Texas 76134
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.